Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Oct;14(4):1103–1105. doi: 10.1128/iai.14.4.1103-1105.1976

Cyclophosphamide pretreatment and protection against malaria.

J F Finerty, E P Krehl
PMCID: PMC415498  PMID: 791863

Abstract

Mice pretreated with cyclophosphamide were able to overcome infection from a lethal malarial strain. The development of resistance was preceded by increased hypersensitivity to malarial antigens. Hypersensitivity was demonstrable by a delayed footpad swelling technique.

Full text

PDF
1103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cozad G. C., Lindsey T. J. Effect of cyclophosphamide on Histoplasma capsulatum infections in mice. Infect Immun. 1974 Feb;9(2):261–265. doi: 10.1128/iai.9.2.261-265.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Finerty J. F., Tobie J. E., Evans C. B. Antibody and immunoglobulin synthesis in germfree and conventional mice infected with Plasmodium berghei. Am J Trop Med Hyg. 1972 Sep;21(5):499–505. doi: 10.4269/ajtmh.1972.21.499. [DOI] [PubMed] [Google Scholar]
  3. Katz S. I., Parker D., Turk J. L. B-cell suppression of delayed hypersensitivity reactions. Nature. 1974 Oct 11;251(5475):550–551. doi: 10.1038/251550a0. [DOI] [PubMed] [Google Scholar]
  4. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Maguire H. C., Jr, Ettore V. L. Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig. J Invest Dermatol. 1967 Jan;48(1):39–43. doi: 10.1038/jid.1967.6. [DOI] [PubMed] [Google Scholar]
  6. Martin W. J., Finerty J., Rosenthal A. Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol. 1971 Oct 27;233(43):260–261. doi: 10.1038/newbio233260a0. [DOI] [PubMed] [Google Scholar]
  7. Santos G. W. Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc. 1967 May-Jun;26(3):907–913. [PubMed] [Google Scholar]
  8. Singer S. H., Ford M., Kirschstein R. L. Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis. Infect Immun. 1972 Jun;5(6):953–956. doi: 10.1128/iai.5.6.953-956.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Spira D. T., Golenser J., Zuckerman A., Neiss R. Multiple modes of action of cyclophosphamide on plasmodial infections in rats. Trans R Soc Trop Med Hyg. 1972;66(6):921–930. doi: 10.1016/0035-9203(72)90129-0. [DOI] [PubMed] [Google Scholar]
  10. Turk J. L., Parker D. Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology. 1973 Apr;24(4):751–758. [PMC free article] [PubMed] [Google Scholar]
  11. Turk J. L., Parker D., Poulter L. W. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology. 1972 Oct;23(4):493–501. [PMC free article] [PubMed] [Google Scholar]
  12. Turk J. L., Poulter L. W. Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol. 1972 Feb;10(2):285–296. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES